Island Pharmaceuticals Ltd has released a press release.
ISLA-101 manufacturing and timeline update
Filed with ASX ·
6ix hasn’t read this filing yet.
Island Pharmaceuticals Ltd on 6ix
Earlier from Island Pharmaceuticals
- Island executes PEACH clinical study CRO agreement
- ISLA-101 Phase 2a clinical trial update
- Island updates API agreement
- Griffith Uni Anti-Viral Molecule Screening Collaboration
- Island granted key Australian patent for ISLA-101
Later from Island Pharmaceuticals
- ISLA-101 manufacturing progress
- Positive analytical results for ISLA-101 capsules
- ILA granted key Canadian patent for ISLA-101
- ISLA101 drug product achieves stability milestone
- IRB approval received for ISLA101 Phase 2a clinical trial
Follow Island Pharmaceuticals into a list and get an email when it puts out news.
Follow Island Pharmaceuticals